Tyndale RF - Search Results

1

Breaking barriers in the genomics and pharmacogenetics of drug addiction.

Ho MK, Goldman D, Heinz A, Kaprio J, Kreek MJ, Li MD, Munafò MR, Tyndale RF. Ho MK, et al. Among authors: tyndale rf. Clin Pharmacol Ther. 2010 Dec;88(6):779-91. doi: 10.1038/clpt.2010.175. Epub 2010 Oct 27. Clin Pharmacol Ther. 2010. PMID: 20981002 Free PMC article. Review.

2

Canadian Native Indians exhibit unique CYP2A6 and CYP2C19 mutant allele frequencies.

Nowak MP, Sellers EM, Tyndale RF. Nowak MP, et al. Among authors: tyndale rf. Clin Pharmacol Ther. 1998 Oct;64(4):378-83. doi: 10.1016/S0009-9236(98)90068-6. Clin Pharmacol Ther. 1998. PMID: 9797794

3

The role of pharmacogenetically-variable cytochrome P450 enzymes in drug abuse and dependence.

Howard LA, Sellers EM, Tyndale RF. Howard LA, et al. Among authors: tyndale rf. Pharmacogenomics. 2002 Mar;3(2):185-99. doi: 10.1517/14622416.3.2.185. Pharmacogenomics. 2002. PMID: 11972441 Review.

4

Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence.

Malaiyandi V, Sellers EM, Tyndale RF. Malaiyandi V, et al. Among authors: tyndale rf. Clin Pharmacol Ther. 2005 Mar;77(3):145-58. doi: 10.1016/j.clpt.2004.10.011. Clin Pharmacol Ther. 2005. PMID: 15735609 Review.

5

Overview of the pharmacogenomics of cigarette smoking.

Ho MK, Tyndale RF. Ho MK, et al. Among authors: tyndale rf. Pharmacogenomics J. 2007 Apr;7(2):81-98. doi: 10.1038/sj.tpj.6500436. Epub 2007 Jan 16. Pharmacogenomics J. 2007. PMID: 17224913 Review.

6

The pharmacogenetics research network: from SNP discovery to clinical drug response.

Giacomini KM, Brett CM, Altman RB, Benowitz NL, Dolan ME, Flockhart DA, Johnson JA, Hayes DF, Klein T, Krauss RM, Kroetz DL, McLeod HL, Nguyen AT, Ratain MJ, Relling MV, Reus V, Roden DM, Schaefer CA, Shuldiner AR, Skaar T, Tantisira K, Tyndale RF, Wang L, Weinshilboum RM, Weiss ST, Zineh I; Pharmacogenetics Research Network. Giacomini KM, et al. Among authors: tyndale rf. Clin Pharmacol Ther. 2007 Mar;81(3):328-45. doi: 10.1038/sj.clpt.6100087. Clin Pharmacol Ther. 2007. PMID: 17339863 Free PMC article. Review.

7

Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism.

Mwenifumbo JC, Lessov-Schlaggar CN, Zhou Q, Krasnow RE, Swan GE, Benowitz NL, Tyndale RF. Mwenifumbo JC, et al. Among authors: tyndale rf. Clin Pharmacol Ther. 2008 Jan;83(1):115-21. doi: 10.1038/sj.clpt.6100246. Epub 2007 May 23. Clin Pharmacol Ther. 2008. PMID: 17522595 Free PMC article. Clinical Trial.

8

A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent.

Ho MK, Mwenifumbo JC, Zhao B, Gillam EM, Tyndale RF. Ho MK, et al. Among authors: tyndale rf. Pharmacogenet Genomics. 2008 Jan;18(1):67-75. doi: 10.1097/FPC.0b013e3282f3606e. Pharmacogenet Genomics. 2008. PMID: 18216723 Free PMC article.

9

Drug addiction: a critical problem calling for novel solutions.

Tyndale R. Tyndale R. Clin Pharmacol Ther. 2008 Apr;83(4):503-6. doi: 10.1038/clpt.2008.11. Clin Pharmacol Ther. 2008. PMID: 18349865 No abstract available.

10

Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent.

Mwenifumbo JC, Al Koudsi N, Ho MK, Zhou Q, Hoffmann EB, Sellers EM, Tyndale RF. Mwenifumbo JC, et al. Among authors: tyndale rf. Hum Mutat. 2008 May;29(5):679-88. doi: 10.1002/humu.20698. Hum Mutat. 2008. PMID: 18360915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

446 results

Search Page

Filters